BOT 3.08% 31.5¢ botanix pharmaceuticals ltd

Picking the Bottom, page-59

  1. 5 Posts.
    lightbulb Created with Sketch. 1
    Hi @bernsta - medium term holder here. Definitely spooked over the last few months but apprecaite all of the opinions and views here helping to keep things in perspective.

    I had been wondering why there has been no announcement regarding the R&D rebate that was highlighted in the last 4C as whilst expected/priced in, it would at least be a nice bit of news to help fill the void. Note: 2018's rebate was announced at the end of November.

    Now reading today's investor pres, the rebate has been revised down from $7M (31 Oct 4C - "The Company is also expecting to receive approximately A$7m in R&D tax incentive in 4Q CY2019) to ~$6M (9 Dec Investor Pres pg 22 - "End Sep 2019 - excludes potential R&D tax concession receipt of ~$6m") and the wording changed from "expecting" to "potential". It would be great if the reasons for this could be explained as I thought the calculations for the R&D Rebate were somehwhat of a know quantity. Cheers.
    Last edited by WIKWIWD: 09/12/19
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
-0.010(3.08%)
Mkt cap ! $572.5M
Open High Low Value Volume
32.0¢ 32.5¢ 31.5¢ $1.378M 4.308M

Buyers (Bids)

No. Vol. Price($)
11 927645 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.